301367.SHE BMC Medical Co. Ltd. A
- Market cap
- CNY 5.10B
- P/E
- 21.8x
- P/B
- 1.64x
- ROE
- 8.0%
- Dividend yield
- 0.82%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 301367.SHE undervalued?
Graham number301367.SHE trades 25.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BMC Medical Co. Ltd. A fundamental analysis
No fundamental analysis for BMC Medical Co. Ltd. A yet.
BMC Medical Co. Ltd. A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BMC Medical Co. Ltd. A
BMC Medical Co., Ltd. researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China and internationally. The company offers home-use non-invasive ventilators, ventilation masks, sleep monitors, high-flow humidified oxygen therapy devices, and oxygen concentrators. It also provides chronic disease management services for respiratory health. BMC Medical Co., Ltd. was founded in 2001 and is based in Beijing, China.
Full company profileBMC Medical Co. Ltd. A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
BMC Medical Co. Ltd. A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 560M | 663M | 1.42B | 1.12B | 843M | 1.16B | 1.45B |
| Gross Profit | 560M | 286M | 589M | 516M | 408M | 614M | 787M |
| Operating Income | 560M | 157M | 408M | 289M | 122M | 242M | 332M |
| EBITDA | - | - | 444M | 355M | 201M | 289M | 304M |
| Net Income | 228M | 146M | 380M | 297M | 155M | 226M | 248M |
| EPS | 3.39 | 2.17 | 4.24 | 3.32 | 1.73 | 2.52 | 1.98 |
| Balance Sheet | |||||||
| Total Assets | 468M | 624M | 2.93B | 2.92B | 3.42B | 3.38B | 3.88B |
| Total Liabilities | 93.2M | 132M | 310M | 132M | 587M | 341M | 745M |
| Shareholders' Equity | 374M | 491M | 2.61B | 2.78B | 2.83B | 3.03B | 3.12B |
| Cash & Short-term Investments | 218M | 114M | 356M | 670M | 525M | 1.07B | 1.43B |
| Cash Flow | |||||||
| Operating Cash Flow | 267M | 104M | 375M | 151M | 154M | 130M | - |
| Capital Expenditure | 15.4M | 10.0M | 23.7M | 24.1M | 15.9M | 32.2M | 33.5M |
| Free Cash Flow | 267M | 94.4M | 351M | 127M | 138M | 97.9M | 65.4M |
| Ratios | |||||||
| ROE | 60.9% | 29.7% | 14.6% | 10.7% | 5.5% | 7.4% | 8.0% |
| ROA | 48.7% | 23.4% | 13.0% | 10.2% | 4.5% | 6.7% | 6.4% |
| Net Profit Margin | 40.7% | 22.0% | 26.9% | 26.5% | 18.4% | 19.5% | 17.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
BMC Medical Co. Ltd. A dividends
- Dividend yield
- 0.82%
- Forward dividend
- 0.47 CNY
- Payout ratio
- 18.6%
- Ex-dividend date
- May 28, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 41.9M | 0.47 | 18.6% |
| 2024 | CNY 65.8M | 0.73 | 42.3% |
| 2023 | CNY 128M | 1.43 | 43.0% |
| 2022 | - | - | - |
| 2021 | CNY 28.8M | 0.43 | 19.8% |
| 2020 | CNY 12.0M | 0.18 | 5.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on May 28, 2026.
Who owns BMC Medical Co. Ltd. A
- Insiders 54.25%
- Institutions 10.30%
- Public & others 35.45%
- Shares outstanding 125M
- Free float 56.6M
BMC Medical Co. Ltd. A company profile
- Company name
- BMC Medical Co. Ltd. A
- Ticker
- 301367.SHE
- ISIN
- CNE100005WQ4
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 923
- Fiscal year end
- December
- Address
- Building 4, Huiya Plaza, Beijing, China, 100073
- Phone
- 86 10 5166 3880
- Website
- bmc-medical.com
About BMC Medical Co. Ltd. A
BMC Medical Co., Ltd. researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China and internationally. The company offers home-use non-invasive ventilators, ventilation masks, sleep monitors, high-flow humidified oxygen therapy devices, and oxygen concentrators. It also provides chronic disease management services for respiratory health. BMC Medical Co., Ltd. was founded in 2001 and is based in Beijing, China.
BMC Medical Co. Ltd. A management
9- Mr. Zhi ZhuangGM & Chairman of the Board · born 1969
- Ms. Nan BaoDeputy GM & Chief Financial Officer · born 1980
- Ms. Bei ChenDeputy GM & Director · born 1963
- Mr. Chengwei GaoDeputy GM & Director · born 1963
- Mr. Mingzhao ZhouDeputy GM & Director · born 1970
- Mr. Yi Cheng DuDeputy GM & Secretary of the Board of Directors · born 1981
- Mr. Jian XuDeputy General Manager · born 1973
- Ms. Fang ZhengDeputy General Manager · born 1983
- Lijuan CaoAccounting Supervisor